Table 2.

Raw incidence (%) of potential PASC symptoms and conditions comparing COVID-19 positive andnegative patients.

	COVID-19 positive (%)			COVID-19 negative (%)
	All (N = 225,723)	Severe (N = 16,862)	Non-severe (N = 208,861)	All (N = 677,448)	Severe (N = 143,592)	Non-severe (N = 533,856)
At least one condition	26.86	34.17	26.42	21.44	19.8	21.84
Systematic conditions	2.69	7.46	2.37	1.87	2.93	1.61
Syndromic conditions	26.15	32.48	25.75	20.83	18.77	21.35
Abdominal pain	3.04	3.66	2.99	2.27	2.15	2.31
Abnormal liver enzyme	0.32	1.17	0.25	0.24	0.43	0.19
Acute kidney injury	0.22	1.32	0.13	0.15	0.42	0.08
Acute respiratory distress syndrome	0.03	0.24	0.01	0.01	0.03	0.01
Arrhythmias	1.43	4.41	1.21	0.95	1.56	0.79
Cardiovascular signs and symptoms	1.16	1.69	1.12	0.88	0.86	0.89
Changes in the taste and smell	0.16	0.08	0.17	0.04	0.02	0.05
Chest pain	1.39	1.69	1.37	0.74	0.68	0.75
Cognitive functions	0.68	1	0.66	0.66	0.62	0.68
Fatigue and malaise	1.74	3.22	1.63	1.3	1.74	1.18
Fever and chills	5.67	9.15	5.41	3.73	3.31	3.84
Fluid and electrolyte	0.56	3.33	0.36	0.39	0.92	0.24
Generalized pain	1.26	1.78	1.22	0.91	1.02	0.88
Hair loss	0.24	0.48	0.22	0.14	0.14	0.14
Headache	2.2	2.33	2.19	1.51	1.23	1.59
Heart disease	0.37	1.67	0.27	0.28	0.62	0.2
Mental health	6.32	8.04	6.19	5.45	5.05	5.55
Musculoskeletal pain	3.53	4.03	3.5	2.79	2.72	2.81
Myocarditis	0.03	0.17	0.02	0.01	0.02	0
Myositis	0.02	0.08	0.02	0.02	0.02	0.01
POTS/dysautonomia	1.03	1.34	1.01	0.71	0.72	0.71
Respiratory signs and symptoms	9.68	15.02	9.31	7.25	6.77	7.38
Skin symptoms	3.62	4.99	3.51	2.7	2.66	2.71
Thrombophlebitis and thromboembolism	0.13	1.02	0.06	0.11	0.33	0.05

Note:

^*indicates no evidence of statistical significance from the two-sample proportion test (see the Supplementary Materials)

Red Symptom: COVID-19 positive higher incidence

Blue Symptom: COVID-19 positive lower incidence (see the Supplementary Materials)